Clinical stage biotech company developing advanced vaccines to prevent and treat Bordetella pertussis-related diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
ILiAD Biotechnologies is a privately held, clinical stage biotechnology company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis. The company is developing and acquiring key technologies, working with leading scientists to overcome the limitations of current vaccines, investigating the impact of B. pertussis in a range of human disease, and is focused on validating its proprietary vaccines in human clinical trials.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
Knott Partners
ILiAD Biotechnologies Valuations & Financials
View real-time NPM data on ILiAD Biotechnologies stock including daily ILiAD Biotechnologies stock price estimates, valuation history, and historical share price information. Access ILiAD Biotechnologies financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track ILiAD Biotechnologies pricing across six independent market signals. Looking for private company due diligence data sources on ILiAD Biotechnologies? Get in touch to learn more.
Similar Companies
like ILiAD Biotechnologies
Color
Healthcare & Life Sciences
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cityblock
Healthcare & Life Sciences
Tech-driven care provider for communities with complex needs.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Benchling
Healthcare & Life Sciences
Cloud based platform for research and development in biotechnology.
Lyra
Healthcare & Life Sciences
Digital health startup using technology to connect companies and employees to mental health providers.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Devoted Health
Healthcare & Life Sciences
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
FAQ
We have answers
ILiAD Biotechnologies stock does not trade on public stock exchanges. ILiAD Biotechnologies stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ILiAD Biotechnologies stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
ILiAD Biotechnologies Stock does not trade on public stock exchanges. In order to sell ILiAD Biotechnologies shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
ILiAD Biotechnologies does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view ILiAD Biotechnologies share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for ILiAD Biotechnologies stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ILiAD Biotechnologies stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ILiAD Biotechnologies stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
ILiAD Biotechnologies is a private company and has not had an IPO. There is currently no ILiAD Biotechnologies IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to ILiAD Biotechnologies IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
